Investigation of Anatomical Correlates of Speech Discrimination
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01781039 |
Recruitment Status
:
Recruiting
First Posted
: January 31, 2013
Last Update Posted
: January 17, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Sensorineural Hearing Loss |
Study Type : | Observational |
Estimated Enrollment : | 100 participants |
Observational Model: | Cohort |
Time Perspective: | Cross-Sectional |
Study Start Date : | January 2013 |
Estimated Primary Completion Date : | January 2020 |
Estimated Study Completion Date : | August 2020 |

- Regression analysis [ Time Frame: February 2014 ]Regression analysis will be used to look for a correlation between measures of sensory cell and auditory neuron survival and speech recognition performance.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 100 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Normal hearing to moderate sensorineural hearing loss
- Sufficient English proficiency to complete speech discrimination testing in English
Exclusion Criteria:
- Hearing loss less than a 45 dB HL pure tone average (average hearing thresholds at 500, 1000 and 2000 Hz)
- Conductive hearing loss
- Neurodegenerative disease

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01781039
United States, Massachusetts | |
Steward St. Elizabeth's Medical Center | Recruiting |
Brighton, Massachusetts, United States, 02135 | |
Contact: Mark Parker, PhD 617-779-7956 mark.parker@steward.org | |
Principal Investigator: Mark Parker, PhD | |
Sub-Investigator: Richard Hoben, AuD |
Principal Investigator: | Mark Parker, PhD | Steward St. Elizabeth's Medical Center |
Additional Information:
Publications of Results:
Other Publications:
Responsible Party: | Mark Parker, Director of Audiology, St. Elizabeth's Medical Center, Steward St. Elizabeth's Medical Center of Boston, Inc. |
ClinicalTrials.gov Identifier: | NCT01781039 History of Changes |
Other Study ID Numbers: |
00652 |
First Posted: | January 31, 2013 Key Record Dates |
Last Update Posted: | January 17, 2018 |
Last Verified: | January 2018 |
Keywords provided by Mark Parker, Steward St. Elizabeth's Medical Center of Boston, Inc.:
"hair cell" "hearing aid" "hearing loss" "auditory nerve" synaptopathy |
Additional relevant MeSH terms:
Hearing Loss Deafness Hearing Loss, Sensorineural Hearing Disorders Ear Diseases |
Otorhinolaryngologic Diseases Sensation Disorders Neurologic Manifestations Nervous System Diseases Signs and Symptoms |